# Y-90 Alone or With Sorafenib for Pre-Transplant Hepatocellular Carcinoma

> **NCT00846131** · PHASE1 · COMPLETED · sponsor: **Northwestern University** · enrollment: 24 (actual)

## Conditions studied

- Hepatocellular Carcinoma

## Interventions

- **DRUG:** Sorafenib
- **DRUG:** Yttrium-90 (Y-90)

## Key facts

- **NCT ID:** NCT00846131
- **Lead sponsor:** Northwestern University
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-02
- **Primary completion:** 2015-07
- **Final completion:** 2016-09
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2016-09-15

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00846131

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00846131, "Y-90 Alone or With Sorafenib for Pre-Transplant Hepatocellular Carcinoma". Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/clinical/NCT00846131. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*